OMI:NYE-Owens & Minor Inc. (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 27.71

Change

-0.24 (-0.86)%

Market Cap

USD 2.07B

Volume

0.53M

Analyst Target

USD 15.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Owens & Minor Inc is a healthcare logistics company that connects the world of medical products to the point of care.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
MCK McKesson Corporation

N/A

USD 70.80B
COR Cencora Inc.

N/A

USD 38.52B
CAH Cardinal Health Inc

N/A

USD 26.32B
NVG Nuveen AMT Free Municipal Cred..

N/A

USD 3.29M

ETFs Containing OMI

FDLS Northern Lights Fund Trus.. 1.02 % 0.00 %

N/A

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 43.80% 100% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.80% 100% F 98% N/A
Trailing 12 Months  
Capital Gain 96.52% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 96.52% 100% F 96% N/A
Trailing 5 Years  
Capital Gain 575.85% 100% F 98% N/A
Dividend Return 0.67% 20% F 2% F
Total Return 576.52% 100% F 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 102.39% 100% F 98% N/A
Dividend Return 102.46% 100% F 98% N/A
Total Return 0.08% 20% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 177.92% 20% F 4% F
Risk Adjusted Return 57.59% 40% F 84% B
Market Capitalization 2.07B 40% F 62% D

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.40 40% 31%
Price/Book Ratio 2.04 100% 41%
Price / Cash Flow Ratio 2.55 100% 68%
Price/Free Cash Flow Ratio 10.15 75% 39%
Management Effectiveness  
Return on Equity -4.42% 50% 21%
Return on Invested Capital 3.65% 40% 38%
Return on Assets 2.61% 40% 51%
Debt to Equity Ratio 204.57% 40% 15%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector